Warming Needle Moxibustion for Alzheimer’s Disease

Autor: Xinming Chen et al.

Journal: Authorea. July 28, 2021., englisch

To systematically research the impact of warming needle moxibustion (WNM) for Alzheimer’s Disease (AD).

Four Chinese databases and six English databases were systematically searched. Randomized controlled trials (RCTs) involving the use of WNM to intervene in AD patients were included. Data were extracted from the included studies and methodological quality was evaluated according to the Cochrane Handbook for Systematic Reviews of Intervention 5.1.0. Meta-analysis was performed using RevMan 5.4 software.

8 RCTs comprising 524 patients were included. The study showed that WNM was more effective in the treatment of AD than acupuncture or pharmacotherapy. The findings were as follows: MMSE (MD=1.01, 95%CI: 0.13, 1.90, P=0.03) and CDR (MD=-0.73, 95%CI: -0.84, -0.61, P<0.00001) for global cognitive function, ADL (MD=-1.84, 95%CI: -2.47, -1.22, P<0.00001) for activities of daily living, Syndrome Differentiation Scale of Dementia (SDSD) (MD=-2.67, 95%CI: -3.62, -1.72, P<0.00001), and the total effective rate of patients (OR=3.89, 95%CI: 2.49, 6.09, P<0.00001). The differences in all indicators were statistically significant.

WNM has a significant effect on improving cognitive function and daily living ability, reducing the symptoms of AD, and increase the total effective rate. WNM is an effective non-pharmacological therapy for patients with AD. Keywords: Warming needle moxibustion, Alzheimer’s disease, Randomized Controlled Trials, systematic review and meta-analysis

Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

What's the choice for goji: Lycium barbarum L. or L. chinense Mill.?
RuyuYao et al.; 2021

Efficacy of acupuncture in the treatment of fibromyalgia
Amnon A. Berger et al; 2021

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease
Chao-Chao Yu et al; 2021


Vorheriger Artikel


Nächster Artikel

Link zum Journal